
Opinion|Videos|August 2, 2024
Patient Burden Associated with Pneumococcal Disease
A medical professional examines the significant patient burden imposed by pneumococcal infections, highlighting how this burden drove the development of innovative vaccine technologies.
Advertisement
Episodes in this series

- Discuss the patient burden of pneumococcal infections that led to the development of novel vaccines.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Targeted Combination Therapy for BRCA2-Mutated Prostate Cancer
2
Targeted ADCs Break Through Barriers in HER2-Positive Breast Cancer
3
Ribociclib Plus Fulvestrant Shows Strong PFS and OS Benefits in Patients With Invasive Lobular Carcinoma
4
Pharmacist Spotlight: Kelly Gable, PharmD, BCPP, FAAPP
5
















































































































































































































